Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Estrogen | 106 | 2023 | 384 | 6.260 |
Why?
|
Estrogen Receptor alpha | 39 | 2022 | 144 | 5.660 |
Why?
|
Breast Neoplasms | 77 | 2023 | 2903 | 2.750 |
Why?
|
Receptors, Progesterone | 38 | 2017 | 167 | 1.960 |
Why?
|
Selective Estrogen Receptor Modulators | 12 | 2022 | 34 | 1.360 |
Why?
|
Estrogens | 17 | 2020 | 200 | 1.340 |
Why?
|
Estrogen Receptor beta | 9 | 2013 | 25 | 1.190 |
Why?
|
Estradiol | 39 | 2020 | 252 | 1.160 |
Why?
|
Ligands | 23 | 2022 | 433 | 1.080 |
Why?
|
Tamoxifen | 21 | 2022 | 168 | 0.950 |
Why?
|
Estrogen Antagonists | 17 | 2022 | 48 | 0.940 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 7 | 2017 | 122 | 0.910 |
Why?
|
Esters | 1 | 2023 | 29 | 0.890 |
Why?
|
Organophosphonates | 1 | 2023 | 50 | 0.890 |
Why?
|
Drug Resistance, Neoplasm | 11 | 2022 | 592 | 0.880 |
Why?
|
Estrogen Receptor Antagonists | 2 | 2019 | 2 | 0.850 |
Why?
|
Endocrinology | 2 | 2013 | 66 | 0.830 |
Why?
|
Binding Sites | 22 | 2018 | 1098 | 0.810 |
Why?
|
Protein Binding | 18 | 2021 | 1456 | 0.790 |
Why?
|
Transcription Factors | 11 | 2022 | 1565 | 0.750 |
Why?
|
Antibodies, Monoclonal | 40 | 1993 | 1376 | 0.730 |
Why?
|
Cell Line, Tumor | 22 | 2021 | 2426 | 0.660 |
Why?
|
Signal Transduction | 16 | 2022 | 3241 | 0.660 |
Why?
|
Tea | 2 | 2008 | 19 | 0.640 |
Why?
|
Cell Nucleus | 25 | 2014 | 579 | 0.640 |
Why?
|
Models, Molecular | 17 | 2021 | 1286 | 0.630 |
Why?
|
Protein Conformation | 10 | 2021 | 881 | 0.620 |
Why?
|
Stilbenes | 3 | 2020 | 25 | 0.620 |
Why?
|
Humans | 149 | 2023 | 86643 | 0.600 |
Why?
|
Mutation, Missense | 2 | 2016 | 276 | 0.600 |
Why?
|
Neoplasms, Hormone-Dependent | 4 | 2013 | 40 | 0.600 |
Why?
|
Mammary Neoplasms, Experimental | 3 | 2019 | 124 | 0.600 |
Why?
|
Antineoplastic Agents, Hormonal | 6 | 2022 | 150 | 0.590 |
Why?
|
Chromatin | 2 | 2016 | 380 | 0.590 |
Why?
|
DNA | 17 | 2022 | 1294 | 0.560 |
Why?
|
Animals | 82 | 2021 | 26582 | 0.560 |
Why?
|
Female | 111 | 2023 | 44532 | 0.550 |
Why?
|
MCF-7 Cells | 13 | 2022 | 106 | 0.540 |
Why?
|
Receptors, Steroid | 4 | 2013 | 42 | 0.530 |
Why?
|
Uterus | 21 | 2018 | 215 | 0.510 |
Why?
|
Crystallography, X-Ray | 11 | 2021 | 485 | 0.500 |
Why?
|
Neoplasm Proteins | 5 | 2013 | 532 | 0.500 |
Why?
|
Chemistry, Organic | 1 | 2013 | 2 | 0.480 |
Why?
|
Genitalia | 1 | 2013 | 21 | 0.470 |
Why?
|
Urogenital Neoplasms | 1 | 2013 | 23 | 0.470 |
Why?
|
Pyrazoles | 4 | 2009 | 153 | 0.460 |
Why?
|
Protein Structure, Tertiary | 10 | 2014 | 736 | 0.440 |
Why?
|
Promoter Regions, Genetic | 10 | 2018 | 937 | 0.440 |
Why?
|
Mutation | 18 | 2022 | 3968 | 0.440 |
Why?
|
Pyrrolidines | 4 | 2022 | 58 | 0.420 |
Why?
|
Transcriptional Activation | 5 | 2017 | 280 | 0.420 |
Why?
|
Trans-Activators | 2 | 2013 | 429 | 0.420 |
Why?
|
Mice | 28 | 2021 | 11352 | 0.410 |
Why?
|
Receptors, Androgen | 6 | 2018 | 113 | 0.410 |
Why?
|
Carrier Proteins | 13 | 2007 | 673 | 0.400 |
Why?
|
Lactate dehydrogenase-elevating virus | 1 | 2011 | 7 | 0.400 |
Why?
|
DNA-Binding Proteins | 8 | 2003 | 1208 | 0.390 |
Why?
|
NF-kappa B | 4 | 2022 | 444 | 0.390 |
Why?
|
Transcription, Genetic | 12 | 2020 | 1135 | 0.390 |
Why?
|
Structure-Activity Relationship | 9 | 2020 | 408 | 0.380 |
Why?
|
Immunohistochemistry | 20 | 2014 | 1753 | 0.380 |
Why?
|
Peptides | 5 | 2019 | 639 | 0.380 |
Why?
|
Gene Knock-In Techniques | 2 | 2009 | 28 | 0.370 |
Why?
|
Transplantation, Heterologous | 1 | 2011 | 363 | 0.360 |
Why?
|
Antineoplastic Agents | 5 | 2022 | 2360 | 0.350 |
Why?
|
Biomedical Research | 1 | 2013 | 376 | 0.350 |
Why?
|
Infertility, Male | 1 | 2009 | 24 | 0.340 |
Why?
|
Protein Structure, Secondary | 7 | 2018 | 330 | 0.330 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2008 | 3 | 0.330 |
Why?
|
Catechin | 1 | 2008 | 19 | 0.330 |
Why?
|
Genome-Wide Association Study | 1 | 2016 | 1621 | 0.330 |
Why?
|
Genome, Human | 1 | 2013 | 756 | 0.330 |
Why?
|
Bridged Bicyclo Compounds | 1 | 2008 | 4 | 0.330 |
Why?
|
STAT3 Transcription Factor | 1 | 2008 | 78 | 0.330 |
Why?
|
Pyrimidines | 2 | 2008 | 370 | 0.320 |
Why?
|
Gene Expression Regulation, Neoplastic | 11 | 2020 | 1197 | 0.320 |
Why?
|
Estrogens, Conjugated (USP) | 1 | 2007 | 16 | 0.310 |
Why?
|
Disease Models, Animal | 5 | 2021 | 2232 | 0.310 |
Why?
|
Cinnamates | 2 | 2016 | 8 | 0.310 |
Why?
|
Gene Expression Regulation | 15 | 2016 | 1920 | 0.300 |
Why?
|
Gene Expression | 6 | 2015 | 1284 | 0.290 |
Why?
|
Molecular Sequence Data | 14 | 2012 | 3030 | 0.290 |
Why?
|
Recombinant Fusion Proteins | 5 | 2005 | 557 | 0.280 |
Why?
|
Cell Line | 21 | 2021 | 2468 | 0.280 |
Why?
|
Neovascularization, Pathologic | 1 | 2008 | 353 | 0.280 |
Why?
|
Molecular Structure | 8 | 2020 | 287 | 0.280 |
Why?
|
Gene Regulatory Networks | 2 | 2020 | 296 | 0.280 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2022 | 1313 | 0.280 |
Why?
|
Phenols | 3 | 2018 | 40 | 0.270 |
Why?
|
Endometrium | 9 | 1989 | 48 | 0.270 |
Why?
|
Indoles | 3 | 2018 | 318 | 0.270 |
Why?
|
Diethylstilbestrol | 5 | 2008 | 119 | 0.270 |
Why?
|
Mammary Glands, Animal | 3 | 2013 | 78 | 0.260 |
Why?
|
Histone Deacetylases | 1 | 2005 | 63 | 0.260 |
Why?
|
Tetrahydronaphthalenes | 2 | 2022 | 15 | 0.260 |
Why?
|
Amino Acid Sequence | 11 | 2018 | 2062 | 0.250 |
Why?
|
Androgen Antagonists | 3 | 2018 | 144 | 0.250 |
Why?
|
Transfection | 8 | 2008 | 896 | 0.250 |
Why?
|
Cell Survival | 6 | 2020 | 969 | 0.250 |
Why?
|
MicroRNAs | 3 | 2015 | 534 | 0.250 |
Why?
|
Unfolded Protein Response | 2 | 2021 | 39 | 0.240 |
Why?
|
Deoxyribonucleotides | 2 | 2023 | 8 | 0.240 |
Why?
|
Transcription Factor AP-1 | 2 | 2000 | 65 | 0.230 |
Why?
|
Demethylation | 1 | 2023 | 9 | 0.230 |
Why?
|
Eukaryotic Cells | 1 | 2003 | 43 | 0.220 |
Why?
|
Estrogen Replacement Therapy | 1 | 2003 | 45 | 0.220 |
Why?
|
Bile Acids and Salts | 1 | 2003 | 61 | 0.220 |
Why?
|
Repressor Proteins | 2 | 2005 | 403 | 0.220 |
Why?
|
History, 21st Century | 2 | 2013 | 175 | 0.220 |
Why?
|
Chrysenes | 1 | 2002 | 1 | 0.220 |
Why?
|
Tumor Cells, Cultured | 15 | 2021 | 1041 | 0.220 |
Why?
|
Immunoenzyme Techniques | 16 | 1995 | 303 | 0.220 |
Why?
|
Rats | 21 | 2021 | 3990 | 0.220 |
Why?
|
History, 20th Century | 2 | 2013 | 312 | 0.210 |
Why?
|
Endometrial Neoplasms | 3 | 2008 | 193 | 0.210 |
Why?
|
Cell Proliferation | 6 | 2021 | 1578 | 0.210 |
Why?
|
Prognosis | 11 | 2018 | 3679 | 0.210 |
Why?
|
Protein Domains | 5 | 2021 | 128 | 0.210 |
Why?
|
Progestins | 3 | 2017 | 22 | 0.210 |
Why?
|
Protein-Tyrosine Kinases | 3 | 2013 | 302 | 0.210 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2022 | 120 | 0.210 |
Why?
|
Hormones | 2 | 2020 | 141 | 0.210 |
Why?
|
Gene Expression Profiling | 5 | 2023 | 1384 | 0.210 |
Why?
|
Proteolysis | 2 | 2021 | 100 | 0.200 |
Why?
|
Leukocyte Elastase | 1 | 2021 | 8 | 0.200 |
Why?
|
Microfilament Proteins | 2 | 2013 | 208 | 0.200 |
Why?
|
Carcinogenesis | 2 | 2021 | 195 | 0.200 |
Why?
|
Genomics | 2 | 2016 | 720 | 0.190 |
Why?
|
Cytosol | 18 | 1995 | 189 | 0.190 |
Why?
|
Response Elements | 2 | 2000 | 63 | 0.190 |
Why?
|
Cricetinae | 11 | 2004 | 560 | 0.190 |
Why?
|
Cell Membrane | 3 | 2014 | 666 | 0.180 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2019 | 8 | 0.180 |
Why?
|
Macrocyclic Compounds | 1 | 2019 | 7 | 0.180 |
Why?
|
Epithelium | 5 | 2013 | 319 | 0.180 |
Why?
|
Cycloaddition Reaction | 1 | 2019 | 6 | 0.180 |
Why?
|
Mutant Proteins | 2 | 2018 | 94 | 0.180 |
Why?
|
Subcellular Fractions | 2 | 2008 | 93 | 0.170 |
Why?
|
Estrogen Receptor Modulators | 1 | 2018 | 10 | 0.170 |
Why?
|
Benzopyrans | 1 | 2018 | 20 | 0.160 |
Why?
|
Receptors, Glucocorticoid | 3 | 2018 | 120 | 0.160 |
Why?
|
Cloning, Molecular | 9 | 2008 | 646 | 0.160 |
Why?
|
Chromatin Immunoprecipitation | 2 | 2016 | 133 | 0.160 |
Why?
|
Ovarian Neoplasms | 4 | 2011 | 744 | 0.160 |
Why?
|
Ejaculatory Ducts | 1 | 1997 | 2 | 0.160 |
Why?
|
Endothelium, Vascular | 3 | 2014 | 435 | 0.160 |
Why?
|
Megestrol Acetate | 1 | 2017 | 10 | 0.160 |
Why?
|
Genitalia, Male | 1 | 1997 | 24 | 0.160 |
Why?
|
Mass Spectrometry | 2 | 1995 | 188 | 0.160 |
Why?
|
Transcriptome | 2 | 2023 | 580 | 0.160 |
Why?
|
Treatment Outcome | 4 | 2021 | 7993 | 0.160 |
Why?
|
Cluster Analysis | 2 | 2016 | 369 | 0.160 |
Why?
|
Hydrogen Bonding | 2 | 2008 | 144 | 0.160 |
Why?
|
Neoplasms | 3 | 2021 | 2898 | 0.150 |
Why?
|
Xenograft Model Antitumor Assays | 5 | 2018 | 458 | 0.150 |
Why?
|
Progesterone | 4 | 1992 | 110 | 0.150 |
Why?
|
Proteins | 3 | 2005 | 777 | 0.150 |
Why?
|
CHO Cells | 8 | 2004 | 187 | 0.150 |
Why?
|
Metabolome | 1 | 2017 | 47 | 0.150 |
Why?
|
Blotting, Western | 8 | 2014 | 782 | 0.150 |
Why?
|
Ovary | 6 | 2011 | 258 | 0.150 |
Why?
|
Cells, Cultured | 9 | 2008 | 2818 | 0.150 |
Why?
|
Eukaryotic Initiation Factor-4A | 1 | 2016 | 2 | 0.150 |
Why?
|
Cell Movement | 3 | 2011 | 758 | 0.150 |
Why?
|
Antibodies | 8 | 1998 | 350 | 0.150 |
Why?
|
Interferons | 1 | 2017 | 133 | 0.150 |
Why?
|
Base Sequence | 14 | 2012 | 2330 | 0.150 |
Why?
|
Carcinoma | 3 | 1996 | 436 | 0.140 |
Why?
|
Breast | 4 | 1993 | 288 | 0.140 |
Why?
|
Enhancer Elements, Genetic | 2 | 2016 | 266 | 0.140 |
Why?
|
Nucleotide Motifs | 1 | 2016 | 47 | 0.140 |
Why?
|
Hydrocarbons | 1 | 2016 | 11 | 0.140 |
Why?
|
Interleukin-11 | 2 | 2013 | 20 | 0.140 |
Why?
|
Sequence Analysis, DNA | 4 | 2016 | 853 | 0.140 |
Why?
|
Social Work | 1 | 1996 | 19 | 0.140 |
Why?
|
Nucleosomes | 1 | 2016 | 54 | 0.140 |
Why?
|
Prolactin | 2 | 2013 | 88 | 0.140 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2008 | 407 | 0.140 |
Why?
|
Psychotherapy | 1 | 1996 | 74 | 0.130 |
Why?
|
Molecular Dynamics Simulation | 4 | 2020 | 245 | 0.130 |
Why?
|
Cultural Diversity | 1 | 1996 | 51 | 0.130 |
Why?
|
Phenotype | 5 | 2016 | 2378 | 0.130 |
Why?
|
Polymerase Chain Reaction | 5 | 2008 | 927 | 0.130 |
Why?
|
Apoptosis | 2 | 2020 | 1683 | 0.130 |
Why?
|
Genes, BRCA1 | 1 | 2016 | 192 | 0.130 |
Why?
|
Estetrol | 1 | 2014 | 1 | 0.130 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2015 | 49 | 0.130 |
Why?
|
Endoplasmic Reticulum | 1 | 2016 | 250 | 0.130 |
Why?
|
Protein Folding | 2 | 2008 | 282 | 0.130 |
Why?
|
Nerve Tissue Proteins | 2 | 2008 | 503 | 0.130 |
Why?
|
Cytoskeleton | 2 | 2013 | 193 | 0.130 |
Why?
|
Chromatography, Affinity | 6 | 2005 | 81 | 0.120 |
Why?
|
Autoradiography | 2 | 2008 | 69 | 0.120 |
Why?
|
Gonadal Steroid Hormones | 2 | 2013 | 50 | 0.120 |
Why?
|
North Dakota | 1 | 2013 | 10 | 0.120 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 266 | 0.120 |
Why?
|
Models, Biological | 4 | 2020 | 1749 | 0.120 |
Why?
|
Radioligand Assay | 7 | 2007 | 32 | 0.120 |
Why?
|
Gene Ontology | 1 | 2013 | 34 | 0.120 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2013 | 86 | 0.120 |
Why?
|
Tissue Fixation | 1 | 1993 | 40 | 0.120 |
Why?
|
Mammary Glands, Human | 1 | 2013 | 22 | 0.120 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2013 | 54 | 0.110 |
Why?
|
Androgens | 1 | 2013 | 167 | 0.110 |
Why?
|
Vimentin | 1 | 2012 | 44 | 0.110 |
Why?
|
Drug Design | 1 | 2013 | 124 | 0.110 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 3 | 1991 | 113 | 0.110 |
Why?
|
Allosteric Regulation | 2 | 2021 | 68 | 0.110 |
Why?
|
Male | 20 | 2018 | 40965 | 0.110 |
Why?
|
Prostate | 3 | 1991 | 378 | 0.110 |
Why?
|
Nuclear Receptor Coactivator 2 | 3 | 2002 | 15 | 0.110 |
Why?
|
Illinois | 1 | 2013 | 462 | 0.110 |
Why?
|
Gene Deletion | 1 | 2013 | 329 | 0.110 |
Why?
|
RNA, Small Interfering | 2 | 2018 | 547 | 0.110 |
Why?
|
Decidua | 1 | 1992 | 19 | 0.110 |
Why?
|
Menopause | 6 | 1991 | 71 | 0.100 |
Why?
|
Sensitivity and Specificity | 4 | 2008 | 1991 | 0.100 |
Why?
|
Peptide Fragments | 4 | 2002 | 460 | 0.100 |
Why?
|
Regulatory Sequences, Nucleic Acid | 3 | 2022 | 148 | 0.100 |
Why?
|
Biomarkers, Tumor | 7 | 2020 | 1464 | 0.100 |
Why?
|
Pregnancy Trimester, First | 1 | 1992 | 63 | 0.100 |
Why?
|
Drug Interactions | 2 | 2011 | 248 | 0.100 |
Why?
|
Menstrual Cycle | 3 | 1988 | 55 | 0.100 |
Why?
|
RNA, Messenger | 11 | 1997 | 1981 | 0.100 |
Why?
|
Dimerization | 3 | 2007 | 143 | 0.100 |
Why?
|
Immunoprecipitation | 2 | 2008 | 134 | 0.100 |
Why?
|
Epithelial-Mesenchymal Transition | 3 | 2020 | 70 | 0.100 |
Why?
|
rac GTP-Binding Proteins | 1 | 2011 | 25 | 0.100 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2014 | 879 | 0.100 |
Why?
|
Rats, Sprague-Dawley | 3 | 2006 | 1219 | 0.100 |
Why?
|
Hippocampus | 3 | 2008 | 442 | 0.090 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2021 | 2438 | 0.090 |
Why?
|
Mice, Nude | 3 | 2018 | 790 | 0.090 |
Why?
|
Cell Culture Techniques | 1 | 2011 | 188 | 0.090 |
Why?
|
Peptide Library | 2 | 2011 | 84 | 0.090 |
Why?
|
Substrate Specificity | 3 | 2017 | 347 | 0.090 |
Why?
|
CREB-Binding Protein | 2 | 2007 | 16 | 0.090 |
Why?
|
Mice, Inbred BALB C | 3 | 2018 | 1047 | 0.090 |
Why?
|
Enzyme Activation | 3 | 2008 | 692 | 0.090 |
Why?
|
Prostatic Neoplasms | 4 | 2018 | 1721 | 0.090 |
Why?
|
Muscle, Smooth, Vascular | 3 | 1999 | 231 | 0.090 |
Why?
|
Neoplasm Invasiveness | 2 | 2011 | 552 | 0.090 |
Why?
|
Seminiferous Epithelium | 1 | 2009 | 2 | 0.090 |
Why?
|
Oligospermia | 1 | 2009 | 4 | 0.090 |
Why?
|
Antigen-Antibody Complex | 7 | 1988 | 87 | 0.090 |
Why?
|
Sertoli Cells | 1 | 2009 | 18 | 0.090 |
Why?
|
Genitalia, Female | 2 | 1986 | 25 | 0.090 |
Why?
|
Pyridines | 3 | 2021 | 310 | 0.090 |
Why?
|
Flow Cytometry | 1 | 2011 | 679 | 0.090 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2011 | 427 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2001 | 222 | 0.090 |
Why?
|
Mice, Mutant Strains | 1 | 2009 | 229 | 0.080 |
Why?
|
Osteosarcoma | 2 | 2006 | 158 | 0.080 |
Why?
|
Protein Conformation, alpha-Helical | 2 | 2018 | 16 | 0.080 |
Why?
|
Neoplasm Metastasis | 5 | 2021 | 1056 | 0.080 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2008 | 78 | 0.080 |
Why?
|
Survival Analysis | 4 | 2018 | 1538 | 0.080 |
Why?
|
Amino Acids | 4 | 2004 | 252 | 0.080 |
Why?
|
Testosterone | 2 | 2009 | 271 | 0.080 |
Why?
|
Piperazines | 2 | 2021 | 272 | 0.080 |
Why?
|
Point Mutation | 1 | 2009 | 246 | 0.080 |
Why?
|
Endothelial Cells | 2 | 2008 | 428 | 0.080 |
Why?
|
Follicle Stimulating Hormone | 1 | 2008 | 147 | 0.080 |
Why?
|
Luteinizing Hormone | 1 | 2008 | 167 | 0.080 |
Why?
|
Embryo, Mammalian | 1 | 2008 | 207 | 0.080 |
Why?
|
Boron | 1 | 2007 | 3 | 0.080 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 376 | 0.080 |
Why?
|
Binding, Competitive | 8 | 1999 | 145 | 0.080 |
Why?
|
Adenocarcinoma | 3 | 2008 | 1169 | 0.080 |
Why?
|
Cattle | 8 | 1986 | 376 | 0.080 |
Why?
|
Estrogens, Non-Steroidal | 1 | 2007 | 30 | 0.080 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 2007 | 47 | 0.080 |
Why?
|
Nitrogen | 1 | 2007 | 70 | 0.070 |
Why?
|
Gene Library | 2 | 2005 | 130 | 0.070 |
Why?
|
Amino Acid Substitution | 1 | 2008 | 339 | 0.070 |
Why?
|
Carbon | 1 | 2007 | 80 | 0.070 |
Why?
|
Interferon-gamma | 1 | 2008 | 444 | 0.070 |
Why?
|
Genistein | 1 | 2006 | 16 | 0.070 |
Why?
|
Phenol | 1 | 2006 | 7 | 0.070 |
Why?
|
Middle Aged | 19 | 2009 | 25028 | 0.070 |
Why?
|
Growth Inhibitors | 1 | 2006 | 41 | 0.070 |
Why?
|
Down-Regulation | 2 | 2018 | 504 | 0.070 |
Why?
|
HeLa Cells | 3 | 2014 | 498 | 0.070 |
Why?
|
Crystallography | 1 | 2006 | 45 | 0.070 |
Why?
|
Predictive Value of Tests | 4 | 2003 | 1673 | 0.070 |
Why?
|
Methionine | 1 | 2006 | 66 | 0.070 |
Why?
|
Disease Progression | 2 | 2023 | 1531 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2008 | 1961 | 0.070 |
Why?
|
Behavior Therapy | 1 | 2006 | 75 | 0.070 |
Why?
|
Rabbits | 7 | 1988 | 636 | 0.070 |
Why?
|
Adipose Tissue | 1 | 2008 | 240 | 0.070 |
Why?
|
Protein Array Analysis | 1 | 2005 | 50 | 0.070 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2005 | 74 | 0.070 |
Why?
|
Aged | 15 | 2009 | 18415 | 0.070 |
Why?
|
Maxillary Sinus Neoplasms | 1 | 1985 | 8 | 0.070 |
Why?
|
Chickens | 7 | 1992 | 212 | 0.060 |
Why?
|
Adult | 17 | 2006 | 25648 | 0.060 |
Why?
|
Protein Interaction Mapping | 1 | 2005 | 82 | 0.060 |
Why?
|
Enzyme Inhibitors | 1 | 2008 | 639 | 0.060 |
Why?
|
Molecular Weight | 7 | 1987 | 332 | 0.060 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2005 | 93 | 0.060 |
Why?
|
Vitellogenins | 4 | 1998 | 10 | 0.060 |
Why?
|
Paranasal Sinus Neoplasms | 1 | 1985 | 24 | 0.060 |
Why?
|
DNA, Neoplasm | 4 | 2020 | 265 | 0.060 |
Why?
|
Weight Loss | 1 | 2006 | 229 | 0.060 |
Why?
|
Protein Engineering | 1 | 2005 | 140 | 0.060 |
Why?
|
Angiogenesis Inhibitors | 1 | 2007 | 311 | 0.060 |
Why?
|
Tissue Distribution | 6 | 1993 | 290 | 0.060 |
Why?
|
HSP70 Heat-Shock Proteins | 2 | 1995 | 113 | 0.060 |
Why?
|
Tritium | 3 | 1997 | 133 | 0.060 |
Why?
|
Molecular Conformation | 1 | 2004 | 96 | 0.060 |
Why?
|
Staining and Labeling | 4 | 1996 | 165 | 0.060 |
Why?
|
COS Cells | 1 | 2004 | 166 | 0.060 |
Why?
|
Recombinant Proteins | 4 | 2017 | 1014 | 0.060 |
Why?
|
Calcium | 1 | 2008 | 1156 | 0.060 |
Why?
|
Cross Reactions | 6 | 2001 | 106 | 0.060 |
Why?
|
Genotype | 1 | 2008 | 1851 | 0.060 |
Why?
|
Helix-Loop-Helix Motifs | 1 | 2022 | 25 | 0.060 |
Why?
|
Luminescent Measurements | 1 | 2003 | 57 | 0.060 |
Why?
|
Kinetics | 7 | 2017 | 1513 | 0.060 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2022 | 41 | 0.050 |
Why?
|
DNA Damage | 2 | 2013 | 366 | 0.050 |
Why?
|
Iodine Radioisotopes | 3 | 1996 | 134 | 0.050 |
Why?
|
Nucleic Acid Conformation | 4 | 1997 | 332 | 0.050 |
Why?
|
Ovariectomy | 2 | 2014 | 81 | 0.050 |
Why?
|
Genes | 3 | 1988 | 305 | 0.050 |
Why?
|
Histocytochemistry | 4 | 1988 | 130 | 0.050 |
Why?
|
Interdisciplinary Communication | 1 | 2003 | 130 | 0.050 |
Why?
|
Raloxifene Hydrochloride | 2 | 2018 | 10 | 0.050 |
Why?
|
Genetic Variation | 1 | 2009 | 1351 | 0.050 |
Why?
|
Immunoglobulins | 2 | 1979 | 148 | 0.050 |
Why?
|
Immunoassay | 6 | 1991 | 92 | 0.050 |
Why?
|
Eosinophil Cationic Protein | 1 | 2021 | 4 | 0.050 |
Why?
|
Secretory Leukocyte Peptidase Inhibitor | 1 | 2021 | 5 | 0.050 |
Why?
|
Coronary Vessels | 2 | 1996 | 177 | 0.050 |
Why?
|
Pancreatic Elastase | 1 | 2021 | 15 | 0.050 |
Why?
|
Neurons | 2 | 2008 | 1546 | 0.050 |
Why?
|
Frozen Sections | 2 | 1993 | 48 | 0.050 |
Why?
|
Receptors, Cell Surface | 4 | 1996 | 286 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2001 | 47 | 0.050 |
Why?
|
Growth Substances | 1 | 2001 | 80 | 0.050 |
Why?
|
Protease Inhibitors | 1 | 2021 | 72 | 0.050 |
Why?
|
X-Box Binding Protein 1 | 1 | 2020 | 17 | 0.050 |
Why?
|
fas Receptor | 1 | 2021 | 75 | 0.050 |
Why?
|
United States | 1 | 2013 | 6672 | 0.050 |
Why?
|
Benzothiazoles | 1 | 2020 | 17 | 0.050 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 5 | 1999 | 268 | 0.050 |
Why?
|
Fluorescence | 1 | 2020 | 102 | 0.050 |
Why?
|
Dogs | 1 | 2021 | 685 | 0.050 |
Why?
|
Histones | 2 | 2021 | 311 | 0.050 |
Why?
|
Protein Isoforms | 1 | 2021 | 270 | 0.050 |
Why?
|
Cell Death | 1 | 2021 | 256 | 0.050 |
Why?
|
Mucoproteins | 1 | 2019 | 14 | 0.050 |
Why?
|
Endoribonucleases | 1 | 2020 | 92 | 0.050 |
Why?
|
GPI-Linked Proteins | 1 | 2019 | 50 | 0.050 |
Why?
|
Species Specificity | 6 | 1988 | 678 | 0.040 |
Why?
|
Carcinoma, Squamous Cell | 2 | 1985 | 1076 | 0.040 |
Why?
|
Swine | 1 | 2021 | 555 | 0.040 |
Why?
|
Thermodynamics | 1 | 2020 | 309 | 0.040 |
Why?
|
Neutrophils | 1 | 2021 | 307 | 0.040 |
Why?
|
Rats, Inbred Strains | 4 | 1993 | 312 | 0.040 |
Why?
|
Stereoisomerism | 2 | 2018 | 102 | 0.040 |
Why?
|
Obesity | 1 | 2006 | 963 | 0.040 |
Why?
|
Oligonucleotides | 3 | 1986 | 92 | 0.040 |
Why?
|
Chemotaxis | 1 | 1999 | 72 | 0.040 |
Why?
|
Oncogene Proteins | 1 | 2019 | 59 | 0.040 |
Why?
|
Peptide Hydrolases | 1 | 2019 | 100 | 0.040 |
Why?
|
Neoplasm Transplantation | 1 | 2020 | 391 | 0.040 |
Why?
|
Tissue Preservation | 3 | 1989 | 14 | 0.040 |
Why?
|
Chromatography, High Pressure Liquid | 3 | 1995 | 315 | 0.040 |
Why?
|
Antibody Specificity | 3 | 2001 | 129 | 0.040 |
Why?
|
Methylation | 3 | 2016 | 251 | 0.040 |
Why?
|
Antibodies, Neutralizing | 1 | 2019 | 112 | 0.040 |
Why?
|
Thymine Nucleotides | 2 | 1975 | 6 | 0.040 |
Why?
|
Cell Adhesion Molecules | 1 | 2019 | 163 | 0.040 |
Why?
|
Aging | 2 | 2013 | 691 | 0.040 |
Why?
|
Epitopes | 4 | 1988 | 255 | 0.040 |
Why?
|
Molecular Docking Simulation | 1 | 2018 | 46 | 0.040 |
Why?
|
Mice, Transgenic | 2 | 2013 | 1540 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2003 | 469 | 0.040 |
Why?
|
Centrifugation, Density Gradient | 4 | 1985 | 112 | 0.040 |
Why?
|
Fallopian Tubes | 3 | 1988 | 41 | 0.040 |
Why?
|
Cervix Uteri | 3 | 1988 | 65 | 0.040 |
Why?
|
Crystallization | 1 | 1998 | 206 | 0.040 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1998 | 279 | 0.040 |
Why?
|
Alkaline Phosphatase | 1 | 2018 | 132 | 0.040 |
Why?
|
Amino Acid Motifs | 1 | 2018 | 116 | 0.040 |
Why?
|
Quality of Life | 1 | 2006 | 1585 | 0.040 |
Why?
|
Troleandomycin | 1 | 2017 | 3 | 0.040 |
Why?
|
Cytochrome P-450 CYP3A Inhibitors | 1 | 2017 | 5 | 0.040 |
Why?
|
Hybrid Cells | 4 | 1987 | 72 | 0.040 |
Why?
|
Myometrium | 4 | 1992 | 46 | 0.040 |
Why?
|
Glucuronides | 1 | 2017 | 34 | 0.040 |
Why?
|
Proton Magnetic Resonance Spectroscopy | 1 | 2017 | 12 | 0.040 |
Why?
|
Ketoconazole | 1 | 2017 | 25 | 0.040 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2017 | 43 | 0.040 |
Why?
|
Microsomes, Liver | 1 | 2017 | 49 | 0.040 |
Why?
|
Microscopy, Electron | 3 | 1993 | 503 | 0.040 |
Why?
|
DNA, Complementary | 2 | 1997 | 393 | 0.040 |
Why?
|
Interferon-Stimulated Gene Factor 3, gamma Subunit | 1 | 2017 | 3 | 0.040 |
Why?
|
STAT2 Transcription Factor | 1 | 2017 | 6 | 0.040 |
Why?
|
Neoplasm Staging | 2 | 1994 | 1939 | 0.040 |
Why?
|
Time Factors | 5 | 2006 | 5210 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2021 | 559 | 0.040 |
Why?
|
Blotting, Northern | 3 | 2007 | 256 | 0.040 |
Why?
|
Oviducts | 5 | 1987 | 6 | 0.040 |
Why?
|
Nucleic Acid Hybridization | 7 | 1996 | 245 | 0.040 |
Why?
|
Umbilical Veins | 1 | 1996 | 46 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 1 | 2021 | 589 | 0.040 |
Why?
|
Oxidation-Reduction | 1 | 2017 | 373 | 0.040 |
Why?
|
ErbB Receptors | 2 | 2004 | 485 | 0.040 |
Why?
|
Egg Proteins | 1 | 1996 | 10 | 0.040 |
Why?
|
Fibroblasts | 1 | 1999 | 729 | 0.040 |
Why?
|
Steroids | 1 | 1997 | 177 | 0.040 |
Why?
|
Chromosome Aberrations | 2 | 1996 | 387 | 0.040 |
Why?
|
Linear Energy Transfer | 1 | 1996 | 5 | 0.040 |
Why?
|
Family Therapy | 1 | 1996 | 16 | 0.030 |
Why?
|
Pregnancy | 4 | 2009 | 2894 | 0.030 |
Why?
|
Aged, 80 and over | 3 | 1996 | 6509 | 0.030 |
Why?
|
Protein Kinases | 2 | 1987 | 209 | 0.030 |
Why?
|
Professional-Patient Relations | 1 | 1996 | 53 | 0.030 |
Why?
|
Vagina | 2 | 1988 | 161 | 0.030 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2016 | 94 | 0.030 |
Why?
|
Hexestrol | 1 | 1995 | 1 | 0.030 |
Why?
|
Azirines | 1 | 1995 | 3 | 0.030 |
Why?
|
Cell Fusion | 3 | 1995 | 39 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2014 | 1924 | 0.030 |
Why?
|
Self Concept | 1 | 1996 | 133 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2006 | 3640 | 0.030 |
Why?
|
Trypsin | 3 | 1995 | 95 | 0.030 |
Why?
|
Prostate-Specific Antigen | 1 | 2017 | 353 | 0.030 |
Why?
|
Animals, Newborn | 2 | 1993 | 510 | 0.030 |
Why?
|
Promegestone | 3 | 1989 | 4 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 2 | 1995 | 416 | 0.030 |
Why?
|
Organophosphorus Compounds | 1 | 1975 | 55 | 0.030 |
Why?
|
Estrenes | 3 | 1989 | 8 | 0.030 |
Why?
|
Isomerases | 1 | 1994 | 9 | 0.030 |
Why?
|
Phosphorylation | 5 | 2004 | 1106 | 0.030 |
Why?
|
Polymorphism, Genetic | 2 | 2009 | 819 | 0.030 |
Why?
|
Protein Disulfide-Isomerases | 1 | 1994 | 18 | 0.030 |
Why?
|
Heterografts | 1 | 2015 | 98 | 0.030 |
Why?
|
Hep G2 Cells | 1 | 2014 | 48 | 0.030 |
Why?
|
Endothelium | 1 | 1994 | 59 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2015 | 187 | 0.030 |
Why?
|
Mice, SCID | 1 | 2015 | 252 | 0.030 |
Why?
|
Uterine Neoplasms | 2 | 1989 | 227 | 0.030 |
Why?
|
Prospective Studies | 2 | 1994 | 4213 | 0.030 |
Why?
|
Exons | 2 | 1993 | 450 | 0.030 |
Why?
|
Progesterone Congeners | 2 | 1992 | 4 | 0.030 |
Why?
|
Pregnenediones | 2 | 1992 | 8 | 0.030 |
Why?
|
Transforming Growth Factor alpha | 1 | 2013 | 50 | 0.030 |
Why?
|
Genes, Reporter | 3 | 1999 | 268 | 0.030 |
Why?
|
Chromosome Mapping | 2 | 1995 | 1074 | 0.030 |
Why?
|
Paraffin Embedding | 1 | 1993 | 78 | 0.030 |
Why?
|
Formaldehyde | 1 | 1993 | 52 | 0.030 |
Why?
|
Lymphatic Metastasis | 3 | 1991 | 486 | 0.030 |
Why?
|
Calibration | 1 | 2013 | 99 | 0.030 |
Why?
|
Suppression, Genetic | 1 | 2013 | 30 | 0.030 |
Why?
|
Scintillation Counting | 2 | 1999 | 5 | 0.030 |
Why?
|
GATA3 Transcription Factor | 1 | 2013 | 48 | 0.030 |
Why?
|
Hematopoietic Stem Cells | 1 | 1995 | 292 | 0.030 |
Why?
|
Polymorphism, Restriction Fragment Length | 2 | 1991 | 147 | 0.030 |
Why?
|
Immunoglobulin G | 3 | 1985 | 456 | 0.030 |
Why?
|
Proportional Hazards Models | 1 | 1994 | 859 | 0.030 |
Why?
|
Escherichia coli | 1 | 1995 | 597 | 0.030 |
Why?
|
Sexual Behavior, Animal | 2 | 2009 | 92 | 0.030 |
Why?
|
Cell Division | 4 | 2001 | 696 | 0.030 |
Why?
|
Drug Resistance | 2 | 1990 | 256 | 0.030 |
Why?
|
Oligodeoxyribonucleotides | 4 | 1995 | 126 | 0.030 |
Why?
|
Doxorubicin | 1 | 2013 | 295 | 0.030 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2013 | 273 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2011 | 83 | 0.030 |
Why?
|
Neuroglia | 1 | 1992 | 104 | 0.030 |
Why?
|
BRCA1 Protein | 1 | 2013 | 200 | 0.030 |
Why?
|
Protein Biosynthesis | 3 | 1989 | 378 | 0.030 |
Why?
|
Epidermal Growth Factor | 2 | 1989 | 119 | 0.030 |
Why?
|
Goats | 3 | 1980 | 18 | 0.030 |
Why?
|
Somatomedins | 2 | 1989 | 28 | 0.030 |
Why?
|
Oligodendroglia | 1 | 1992 | 123 | 0.030 |
Why?
|
Cell Cycle | 1 | 2013 | 502 | 0.020 |
Why?
|
Receptors, Estradiol | 4 | 1984 | 5 | 0.020 |
Why?
|
DNA Repair | 1 | 2013 | 356 | 0.020 |
Why?
|
Polyunsaturated Alkamides | 1 | 1990 | 6 | 0.020 |
Why?
|
Cadmium | 1 | 1990 | 28 | 0.020 |
Why?
|
Simian virus 40 | 1 | 1990 | 35 | 0.020 |
Why?
|
Metallothionein | 1 | 1990 | 13 | 0.020 |
Why?
|
Xenopus laevis | 3 | 1998 | 137 | 0.020 |
Why?
|
Brain | 2 | 1992 | 2216 | 0.020 |
Why?
|
Survival Rate | 1 | 1994 | 1863 | 0.020 |
Why?
|
Breast Diseases | 1 | 1991 | 97 | 0.020 |
Why?
|
Gene Amplification | 1 | 1990 | 131 | 0.020 |
Why?
|
Muscle, Smooth | 1 | 1991 | 354 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2011 | 236 | 0.020 |
Why?
|
Aziridines | 1 | 1989 | 9 | 0.020 |
Why?
|
Combined Modality Therapy | 2 | 2003 | 1686 | 0.020 |
Why?
|
Ketones | 1 | 1989 | 13 | 0.020 |
Why?
|
Paraffin | 1 | 1989 | 4 | 0.020 |
Why?
|
Endometrial Hyperplasia | 1 | 1989 | 8 | 0.020 |
Why?
|
Superovulation | 1 | 2009 | 9 | 0.020 |
Why?
|
Sequence Homology, Nucleic Acid | 4 | 1996 | 173 | 0.020 |
Why?
|
Norpregnadienes | 1 | 1989 | 7 | 0.020 |
Why?
|
Hawaii | 1 | 2009 | 26 | 0.020 |
Why?
|
Infertility | 1 | 2009 | 37 | 0.020 |
Why?
|
Ovarian Follicle | 1 | 2009 | 72 | 0.020 |
Why?
|
Temperature | 2 | 1984 | 396 | 0.020 |
Why?
|
Aromatase | 1 | 1988 | 12 | 0.020 |
Why?
|
Genes, Regulator | 1 | 1989 | 65 | 0.020 |
Why?
|
Cysteine | 1 | 1989 | 135 | 0.020 |
Why?
|
Computer Simulation | 1 | 2013 | 1078 | 0.020 |
Why?
|
Alleles | 2 | 2009 | 1128 | 0.020 |
Why?
|
Insulin-Like Growth Factor I | 1 | 1989 | 114 | 0.020 |
Why?
|
Carotid Artery, Internal | 1 | 1988 | 69 | 0.020 |
Why?
|
Cricetulus | 2 | 2004 | 126 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 1992 | 645 | 0.020 |
Why?
|
Thymidine | 2 | 1999 | 59 | 0.020 |
Why?
|
Osteoblasts | 1 | 1988 | 95 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2014 | 3092 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2007 | 72 | 0.020 |
Why?
|
Transcription Factor RelA | 1 | 2007 | 49 | 0.020 |
Why?
|
Chemokine CCL2 | 1 | 2007 | 47 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2007 | 86 | 0.020 |
Why?
|
Isomerism | 1 | 2007 | 28 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2009 | 916 | 0.020 |
Why?
|
Epithelial Cells | 1 | 1991 | 669 | 0.020 |
Why?
|
Guinea Pigs | 3 | 1989 | 171 | 0.020 |
Why?
|
Hemorrhage | 1 | 2009 | 268 | 0.020 |
Why?
|
Methods | 2 | 1985 | 152 | 0.020 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 1987 | 106 | 0.020 |
Why?
|
Oncogenes | 1 | 1987 | 88 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2007 | 316 | 0.020 |
Why?
|
Aorta | 1 | 1988 | 280 | 0.020 |
Why?
|
Odds Ratio | 1 | 2009 | 678 | 0.020 |
Why?
|
Rhode Island | 1 | 2006 | 9 | 0.020 |
Why?
|
Adenine Nucleotides | 1 | 1986 | 63 | 0.020 |
Why?
|
Endometriosis | 1 | 1987 | 58 | 0.020 |
Why?
|
Nutritional Sciences | 1 | 2006 | 12 | 0.020 |
Why?
|
Endopeptidases | 2 | 1998 | 116 | 0.020 |
Why?
|
Chloramphenicol O-Acetyltransferase | 2 | 1999 | 28 | 0.020 |
Why?
|
Histocompatibility Antigens | 1 | 1986 | 35 | 0.020 |
Why?
|
Leukocyte Common Antigens | 1 | 1986 | 46 | 0.020 |
Why?
|
Transformation, Genetic | 1 | 1986 | 40 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2007 | 256 | 0.020 |
Why?
|
Collodion | 1 | 1985 | 7 | 0.020 |
Why?
|
Conserved Sequence | 2 | 1997 | 210 | 0.020 |
Why?
|
Chromatography, Gel | 1 | 1985 | 103 | 0.020 |
Why?
|
Myocardium | 1 | 1988 | 529 | 0.020 |
Why?
|
Antibody Affinity | 1 | 1985 | 38 | 0.020 |
Why?
|
Thiophenes | 1 | 1985 | 48 | 0.020 |
Why?
|
Hydrolysis | 2 | 1995 | 141 | 0.020 |
Why?
|
Overweight | 1 | 2006 | 118 | 0.020 |
Why?
|
Life Style | 1 | 2006 | 189 | 0.020 |
Why?
|
Gold | 1 | 2005 | 41 | 0.020 |
Why?
|
Histological Techniques | 1 | 1985 | 35 | 0.020 |
Why?
|
Counseling | 1 | 2006 | 145 | 0.020 |
Why?
|
Ovulation | 1 | 1984 | 68 | 0.020 |
Why?
|
Immunoglobulin Idiotypes | 1 | 1984 | 12 | 0.020 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2004 | 7 | 0.020 |
Why?
|
Child | 1 | 1996 | 6927 | 0.020 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2004 | 19 | 0.020 |
Why?
|
Fixatives | 1 | 1984 | 12 | 0.020 |
Why?
|
Cell Physiological Phenomena | 1 | 2004 | 24 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2004 | 115 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2007 | 683 | 0.010 |
Why?
|
Neoplastic Stem Cells | 1 | 1985 | 143 | 0.010 |
Why?
|
Cross-Linking Reagents | 2 | 1999 | 86 | 0.010 |
Why?
|
Feeding Behavior | 1 | 2006 | 324 | 0.010 |
Why?
|
Cyclic AMP | 1 | 2004 | 273 | 0.010 |
Why?
|
Solubility | 1 | 1984 | 177 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2004 | 262 | 0.010 |
Why?
|
Guanine | 2 | 1998 | 208 | 0.010 |
Why?
|
Genes, erbB-2 | 1 | 2003 | 24 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2006 | 351 | 0.010 |
Why?
|
Cytoplasm | 1 | 1984 | 281 | 0.010 |
Why?
|
Autoantibodies | 1 | 1984 | 267 | 0.010 |
Why?
|
Exercise | 1 | 2006 | 315 | 0.010 |
Why?
|
Stem Cells | 1 | 1985 | 351 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2011 | 2271 | 0.010 |
Why?
|
Androstane-3,17-diol | 1 | 1982 | 3 | 0.010 |
Why?
|
Androstanols | 1 | 1982 | 10 | 0.010 |
Why?
|
Serine Endopeptidases | 2 | 1995 | 145 | 0.010 |
Why?
|
Colonic Neoplasms | 1 | 1987 | 556 | 0.010 |
Why?
|
Hybridomas | 1 | 1982 | 74 | 0.010 |
Why?
|
Cohort Studies | 1 | 2009 | 2767 | 0.010 |
Why?
|
Rats, Inbred Lew | 1 | 1982 | 186 | 0.010 |
Why?
|
Liver | 1 | 1987 | 1230 | 0.010 |
Why?
|
Phytotherapy | 1 | 2003 | 133 | 0.010 |
Why?
|
Lung | 1 | 1988 | 1170 | 0.010 |
Why?
|
Research | 1 | 2003 | 253 | 0.010 |
Why?
|
MAP Kinase Kinase 5 | 1 | 2001 | 11 | 0.010 |
Why?
|
MAP Kinase Kinase 2 | 1 | 2001 | 14 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 1 | 2001 | 21 | 0.010 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2001 | 36 | 0.010 |
Why?
|
Blotting, Southern | 2 | 1991 | 129 | 0.010 |
Why?
|
Immunologic Techniques | 1 | 1980 | 27 | 0.010 |
Why?
|
Fibrocystic Breast Disease | 2 | 1991 | 12 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2001 | 101 | 0.010 |
Why?
|
Myeloma Proteins | 1 | 1980 | 32 | 0.010 |
Why?
|
Antibody Formation | 1 | 1980 | 171 | 0.010 |
Why?
|
NADH, NADPH Oxidoreductases | 1 | 1999 | 10 | 0.010 |
Why?
|
Chemotactic Factors | 1 | 1999 | 14 | 0.010 |
Why?
|
Lymphocytes | 1 | 1982 | 464 | 0.010 |
Why?
|
Multienzyme Complexes | 1 | 1999 | 64 | 0.010 |
Why?
|
Transcription Factor TFIIB | 1 | 1999 | 2 | 0.010 |
Why?
|
Titrimetry | 1 | 1999 | 15 | 0.010 |
Why?
|
Clone Cells | 1 | 1980 | 213 | 0.010 |
Why?
|
Polytetrafluoroethylene | 1 | 1999 | 74 | 0.010 |
Why?
|
Nucleocytoplasmic Transport Proteins | 1 | 1999 | 12 | 0.010 |
Why?
|
Nuclear Receptor Coactivator 1 | 1 | 1999 | 24 | 0.010 |
Why?
|
Immunoglobulin M | 1 | 1980 | 154 | 0.010 |
Why?
|
Histone Acetyltransferases | 1 | 1999 | 38 | 0.010 |
Why?
|
Culture Media, Conditioned | 1 | 1999 | 104 | 0.010 |
Why?
|
Inositol 1,4,5-Trisphosphate | 1 | 1999 | 28 | 0.010 |
Why?
|
NADPH Oxidases | 1 | 1999 | 81 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 1999 | 155 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 1999 | 74 | 0.010 |
Why?
|
Cytokines | 1 | 2003 | 776 | 0.010 |
Why?
|
Prostheses and Implants | 1 | 1999 | 121 | 0.010 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 85 | 0.010 |
Why?
|
Neoplasms, Experimental | 1 | 1980 | 269 | 0.010 |
Why?
|
Lymphoma | 1 | 1980 | 262 | 0.010 |
Why?
|
Cell Communication | 1 | 1999 | 194 | 0.010 |
Why?
|
Stromal Cells | 1 | 1999 | 143 | 0.010 |
Why?
|
Antigens | 1 | 1980 | 228 | 0.010 |
Why?
|
Adenylyl Cyclases | 1 | 1999 | 100 | 0.010 |
Why?
|
Receptors, Thyroid Hormone | 1 | 1999 | 159 | 0.010 |
Why?
|
Fibrosis | 1 | 1999 | 203 | 0.010 |
Why?
|
Mifepristone | 2 | 1989 | 33 | 0.010 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 1999 | 113 | 0.010 |
Why?
|
Carotid Arteries | 1 | 1999 | 127 | 0.010 |
Why?
|
Aorta, Thoracic | 1 | 1999 | 165 | 0.010 |
Why?
|
Mouth Floor | 1 | 1978 | 4 | 0.010 |
Why?
|
Epitope Mapping | 1 | 1998 | 16 | 0.010 |
Why?
|
GTP-Binding Proteins | 1 | 1999 | 146 | 0.010 |
Why?
|
DNA Footprinting | 1 | 1998 | 18 | 0.010 |
Why?
|
Cell Adhesion | 1 | 1999 | 420 | 0.010 |
Why?
|
Multiple Myeloma | 1 | 1982 | 307 | 0.010 |
Why?
|
Triiodothyronine | 1 | 1999 | 339 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 1999 | 302 | 0.010 |
Why?
|
Wound Healing | 1 | 1999 | 344 | 0.010 |
Why?
|
Nitrogen Isotopes | 2 | 1988 | 14 | 0.010 |
Why?
|
RNA-Binding Proteins | 1 | 1999 | 246 | 0.010 |
Why?
|
Carbon Isotopes | 2 | 1988 | 76 | 0.010 |
Why?
|
Deuterium | 2 | 1988 | 33 | 0.010 |
Why?
|
Electrophoresis | 1 | 1996 | 55 | 0.010 |
Why?
|
Genetic Vectors | 2 | 1989 | 439 | 0.010 |
Why?
|
Trefoil Factor-1 | 1 | 1996 | 2 | 0.010 |
Why?
|
Yeasts | 1 | 1996 | 49 | 0.010 |
Why?
|
Ribonucleases | 1 | 1996 | 92 | 0.010 |
Why?
|
Piperidines | 1 | 1997 | 181 | 0.010 |
Why?
|
Thermolysin | 1 | 1995 | 9 | 0.010 |
Why?
|
Sequence Alignment | 1 | 1997 | 351 | 0.010 |
Why?
|
Peptide Mapping | 1 | 1995 | 26 | 0.010 |
Why?
|
Chymotrypsin | 1 | 1995 | 28 | 0.010 |
Why?
|
Mouth Neoplasms | 1 | 1978 | 194 | 0.010 |
Why?
|
Chromatography, Paper | 1 | 1975 | 11 | 0.010 |
Why?
|
Phosphines | 1 | 1975 | 4 | 0.010 |
Why?
|
Chemistry | 1 | 1975 | 54 | 0.010 |
Why?
|
Azides | 1 | 1975 | 11 | 0.010 |
Why?
|
Chemical Phenomena | 1 | 1975 | 72 | 0.010 |
Why?
|
Metalloendopeptidases | 1 | 1995 | 45 | 0.010 |
Why?
|
Arteries | 1 | 1996 | 176 | 0.010 |
Why?
|
Models, Genetic | 1 | 2000 | 926 | 0.010 |
Why?
|
Disulfides | 1 | 1975 | 64 | 0.010 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 1995 | 54 | 0.010 |
Why?
|
Radiation Dosage | 1 | 1996 | 227 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 1999 | 696 | 0.010 |
Why?
|
Postmenopause | 1 | 1995 | 98 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 1996 | 279 | 0.010 |
Why?
|
Tissue Extracts | 1 | 1993 | 24 | 0.010 |
Why?
|
Fetus | 1 | 1995 | 226 | 0.010 |
Why?
|
Castration | 2 | 1984 | 41 | 0.010 |
Why?
|
Bone Marrow | 1 | 1995 | 435 | 0.010 |
Why?
|
Genetic Linkage | 1 | 1995 | 623 | 0.010 |
Why?
|
Leukemia | 1 | 1995 | 320 | 0.010 |
Why?
|
Cycloheximide | 1 | 1992 | 56 | 0.010 |
Why?
|
Adolescent | 1 | 1985 | 8981 | 0.010 |
Why?
|
Proto-Oncogenes | 1 | 1992 | 61 | 0.010 |
Why?
|
Genes, Dominant | 1 | 1992 | 117 | 0.010 |
Why?
|
Deoxyribonuclease HindIII | 1 | 1991 | 5 | 0.010 |
Why?
|
Xenopus | 1 | 1992 | 125 | 0.010 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 1 | 1991 | 30 | 0.010 |
Why?
|
Adenofibroma | 1 | 1991 | 5 | 0.010 |
Why?
|
Retrospective Studies | 1 | 1985 | 8489 | 0.010 |
Why?
|
Biopsy | 1 | 1995 | 1163 | 0.010 |
Why?
|
Papilloma | 1 | 1991 | 22 | 0.010 |
Why?
|
Carcinoma in Situ | 1 | 1991 | 53 | 0.010 |
Why?
|
Receptor, ErbB-2 | 1 | 1992 | 223 | 0.010 |
Why?
|
Preoptic Area | 1 | 1989 | 6 | 0.010 |
Why?
|
Cyanogen Bromide | 1 | 1989 | 9 | 0.010 |
Why?
|
Affinity Labels | 1 | 1989 | 10 | 0.010 |
Why?
|
Alkylation | 1 | 1989 | 31 | 0.010 |
Why?
|
Placenta | 1 | 1991 | 175 | 0.010 |
Why?
|
Receptors, Calcitriol | 1 | 1991 | 129 | 0.010 |
Why?
|
Saccharomyces cerevisiae | 1 | 1993 | 434 | 0.010 |
Why?
|
Sex Characteristics | 1 | 1992 | 319 | 0.010 |
Why?
|
Hypothalamus | 1 | 1989 | 79 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 1990 | 235 | 0.010 |
Why?
|
Receptors, Purinergic | 1 | 1989 | 7 | 0.010 |
Why?
|
DNA, Recombinant | 1 | 1989 | 67 | 0.010 |
Why?
|
Metribolone | 1 | 1988 | 5 | 0.010 |
Why?
|
Procollagen | 1 | 1988 | 8 | 0.010 |
Why?
|
Microscopy, Phase-Contrast | 1 | 1988 | 31 | 0.010 |
Why?
|
Transforming Growth Factors | 1 | 1988 | 12 | 0.010 |
Why?
|
Orchiectomy | 1 | 1988 | 68 | 0.010 |
Why?
|
Phenolsulfonphthalein | 1 | 1988 | 3 | 0.010 |
Why?
|
Plasmids | 1 | 1989 | 287 | 0.010 |
Why?
|
Phosphorus Radioisotopes | 1 | 1987 | 19 | 0.000 |
Why?
|
Leukocytes | 1 | 1989 | 202 | 0.000 |
Why?
|
Pituitary Gland | 1 | 1988 | 117 | 0.000 |
Why?
|
Metaphase | 1 | 1987 | 25 | 0.000 |
Why?
|
Ethinyl Estradiol | 1 | 1987 | 16 | 0.000 |
Why?
|
Oncogene Proteins v-erbA | 1 | 1987 | 1 | 0.000 |
Why?
|
Retroviridae Proteins | 1 | 1987 | 5 | 0.000 |
Why?
|
Phosphates | 1 | 1987 | 160 | 0.000 |
Why?
|
Macaca mulatta | 1 | 1988 | 459 | 0.000 |
Why?
|
Poly A | 1 | 1986 | 23 | 0.000 |
Why?
|
Imidoesters | 1 | 1985 | 1 | 0.000 |
Why?
|
Isotope Labeling | 1 | 1985 | 51 | 0.000 |
Why?
|
Macromolecular Substances | 1 | 1985 | 177 | 0.000 |
Why?
|
Drug Implants | 1 | 1984 | 34 | 0.000 |
Why?
|
Macaca fascicularis | 1 | 1984 | 108 | 0.000 |
Why?
|
Receptors, Thyrotropin | 1 | 1984 | 47 | 0.000 |
Why?
|
Receptors, LDL | 1 | 1984 | 53 | 0.000 |
Why?
|
Receptors, Adrenergic, beta | 1 | 1984 | 72 | 0.000 |
Why?
|
Myasthenia Gravis | 1 | 1984 | 83 | 0.000 |
Why?
|
Colon | 1 | 1987 | 496 | 0.000 |
Why?
|
Receptors, Nicotinic | 1 | 1984 | 129 | 0.000 |
Why?
|
Thyrotropin | 1 | 1984 | 280 | 0.000 |
Why?
|
Cell Fractionation | 1 | 1983 | 71 | 0.000 |
Why?
|
Hypophysectomy | 1 | 1982 | 27 | 0.000 |
Why?
|
Prostatic Hyperplasia | 1 | 1983 | 88 | 0.000 |
Why?
|
Adrenalectomy | 1 | 1982 | 43 | 0.000 |
Why?
|
RNA | 1 | 1986 | 560 | 0.000 |
Why?
|
In Vitro Techniques | 1 | 1983 | 989 | 0.000 |
Why?
|
Insulin | 1 | 1984 | 1160 | 0.000 |
Why?
|
Neoplasms, Multiple Primary | 1 | 1978 | 100 | 0.000 |
Why?
|
Phosphorus Compounds | 1 | 1974 | 2 | 0.000 |
Why?
|
Indicators and Reagents | 1 | 1974 | 72 | 0.000 |
Why?
|